Surface Oncology, Inc. Company Profile

04:21 EDT 22nd March 2019 | BioPortfolio

Surface is creating the next generation of immunotherapies for cancer. To fully unlock the potential of cancer immunotherapy, Surface is targeting a broader set of immune processes by which cancer cells evade immune recognition and attack. Our programs are built upon emerging, proprietary insights about how to improve the immune system’s recognition and elimination of cancer cells. These include new approaches to improve the effectiveness of antigen presentation to the adaptive immune system, to block the activity of a variety of suppressor cells in the tumor microenvironment, and to counter the immunosuppressive environment that selectively accumulates in and around the tumor. By targeting the interface of innate and adaptive immunity, Surface hopes to expand the reach of cancer immunotherapy to all patients in need of better treatment. The company was founded by Atlas Venture in 2014. Current investors in the company include Atlas Venture, F‐Prime Capital, Lilly Ventures, and New Enterprise Associates, Inc. (NEA), as well as Novartis, Amgen Ventures, and Elliott Sigal, the former head of R&D at Bristol‐Myers.

News Articles [872 Associated News Articles listed on BioPortfolio]

Surface Oncology Scales Down Lead Program After Safety Concerns Are Discovered

Shares of the company stock plunged in premarket trading after Surface Oncology announced it was scaling back its lead program.

Safety Signal Prompts Surface Oncology to Scale Down Lead Program

Signs of a safety problem have Surface Oncology cutting back clinical trial plans for its lead drug only eight months after the company completed a $108 million IPO to finance clinical tests of the dr...

Surface Oncology execs join MPM

Surface Oncology Added to the NASDAQ Biotechnology Index

CAMBRIDGE, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor micro...

Surface Oncology Announces Upcoming Investor Presentations

CAMBRIDGE, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microe...

Surface Oncology to Present at the 39th Annual Cowen Healthcare Conference

CAMBRIDGE, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor micro...

Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388

IL-27 is a key regulator of checkpoint protein expressionSRF388 believed to be the only anti-IL-27 targeted agent in late-preclinical developmentInvestigational New Drug (IND) submission for SRF388 e...

Surface Oncology Resets Portfolio Priorities, Extends Cash Runway Through 2021

Significantly reduces scope of its CD47 program, SRF231Accelerates IND filing for SRF388 (IL-27) into Q4 2019IND filing for SRF617 (CD39) remains on track for Q4 2019 CAMBRIDGE, Mass., Dec. 18...

Drugs and Medications [10 Associated Drugs and Medications listed on BioPortfolio]

Neutrexin (trimetrexate glucuronate for injection) [medimmune oncology, inc.]

NEUTREXIN (trimetrexate glucuronate for injection)

Rubraca [clovis oncology, inc.]

These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA.RUBRACA (rucaparib) tablets, for oral useInitial U.S. App...

Carboplatin [sagent pharmaceuticals]

Carboplatin Injection(carboplatin aqueous solution)

Carboplatin [meitheal pharmaceuticals inc.]

Carboplatin Injection(carboplatin aqueous solution)

Carboplatin [hospira, inc.]

Carboplatin Injection

PubMed Articles [2695 Associated PubMed Articles listed on BioPortfolio]

Re: The American Society of Peritoneal Surface Malignancies Multi-Institution Evaluation of 1,051 Advanced Ovarian Cancer Patients Undergoing Cytoreductive Surgery and HIPEC: An Introduction of the Peritoneal Surface Disease Severity Score. Journal of Surgical Oncology 2016;114(7):779-784.

Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy.

To investigate the isodose surface volumes (ISVs) for 85, 75 and 60 Gy EQD2 for locally advanced cervix cancer patients.

Communication training in oncology needs a theoretical framework.

"Neuro-oncology research in Nigeria: a great untapped potential".

Nigeria has the largest population in Africa and has sub-optimal access to neuro-oncology care. It has been estimated that there is approximately 1 neurosurgeon to 2.4 million people in the country, w...

Rapid Multi-Site Remote Surface Dosimetry for Total Skin Electron Therapy: Scintillator Target Imaging.

The goal of this work is to produce a surface dosimetry method capable of accurately and remotely measuring skin dose for patients undergoing total skin electron therapy (TSET) without the need for po...

Clinical Trials [1642 Associated Clinical Trials listed on BioPortfolio]

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa

The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to ...

Companies [967 Associated Companies listed on BioPortfolio]

Surface Oncology

Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of ca...


Visualizing Protein Complexes• A Pair of Polyhedra• Surface Buried in an Interface• Computing a Surface Between Two Densities• Polyhedra Evaluated at an Interfacial Surface• Densities Evalua...

EOS Surfaces, LLC

EOS Surfaces, LLC is a solid surface manufacturer, founded in 2005, which revolutionized the solid surface industry with the first 3cm surface, a change from most ½” solid...

Surface Oncology, Inc.

Surface is creating the next generation of immunotherapies for cancer. To fully unlock the potential of cancer immunotherapy, Surface is targeting a broader set of immune processe...

Titan Spine, LLC

Titan Spine, LLC is a surface technology company focused on the design and manufacture of interbody fusion devices for the spine. The company is committed to advancing the science...

More Information about "Surface Oncology, Inc." on BioPortfolio

We have published hundreds of Surface Oncology, Inc. news stories on BioPortfolio along with dozens of Surface Oncology, Inc. Clinical Trials and PubMed Articles about Surface Oncology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Surface Oncology, Inc. Companies in our database. You can also find out about relevant Surface Oncology, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record